| scholarly article | Q13442814 |
| P50 | author | Patrizia Casaccia | Q63315510 |
| P2093 | author name string | Richard Reynolds | |
| Jin Young Kim | |||
| Siming Shen | |||
| Ye He | |||
| Karen Dietz | |||
| Owain Howell | |||
| P2860 | cites work | The bovine herpesvirus 1 immediate-early protein (bICP0) associates with histone deacetylase 1 to activate transcription | Q24291697 |
| HDAC6 is a microtubule-associated deacetylase | Q24298013 | ||
| Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport | Q24300855 | ||
| The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress | Q24301895 | ||
| Glutamate excitotoxicity in a model of multiple sclerosis | Q60450917 | ||
| Kinesin-mediated transport of neurofilament protein oligomers in growing axons | Q73087769 | ||
| Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation | Q73822019 | ||
| Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis | Q80112328 | ||
| Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells | Q24529064 | ||
| Histone deacetylases (HDACs): characterization of the classical HDAC family | Q24535587 | ||
| Regulation of transcription factor YY1 by acetylation and deacetylation | Q24550859 | ||
| Inhibition of p53 transcriptional activity: a potential target for future development of therapeutic strategies for primary demyelination | Q24627168 | ||
| The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves | Q24806766 | ||
| Regulation of neuronal traits by a novel transcriptional complex | Q28214009 | ||
| HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo | Q28510434 | ||
| Identification of a signal for rapid export of proteins from the nucleus | Q29547742 | ||
| Axonal transection in the lesions of multiple sclerosis | Q29615585 | ||
| Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA | Q29620175 | ||
| Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency | Q30052479 | ||
| Impaired axonal transport and altered axolemmal permeability occur in distinct populations of damaged axons following traumatic brain injury | Q30434742 | ||
| Class II histone deacetylases: from sequence to function, regulation, and clinical implication | Q33724483 | ||
| Neuroprotection by histone deacetylase-related protein | Q34564841 | ||
| The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage | Q36299396 | ||
| Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein | Q36677512 | ||
| Pathogenesis of axonal and neuronal damage in multiple sclerosis | Q36840382 | ||
| Mechanisms of neuronal damage in multiple sclerosis and its animal models: role of calcium pumps and exchangers | Q36979460 | ||
| Histone deacetylase inhibitors prevent p53-dependent and p53-independent Bax-mediated neuronal apoptosis through two distinct mechanisms | Q37169993 | ||
| Diffuse axonal injury in non-missile head injury | Q37274633 | ||
| Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis | Q37398059 | ||
| Axonal transport defects in neurodegenerative diseases | Q37614744 | ||
| Excitotoxicity mediated by non-NMDA receptors causes distal axonopathy in long-term cultured spinal motor neurons. | Q39100374 | ||
| Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation | Q40152899 | ||
| Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. | Q40634789 | ||
| Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells | Q40693659 | ||
| Phosphorylation-related immunoreactivity and the rate of transport of neurofilaments in chronic 2,5-hexanedione intoxication | Q41138743 | ||
| Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors | Q41612066 | ||
| Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons | Q41644415 | ||
| Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain | Q42000714 | ||
| Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease | Q42474769 | ||
| Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. | Q44365117 | ||
| Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress Bcl-2. | Q44914263 | ||
| Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein | Q45290027 | ||
| Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. | Q46157039 | ||
| Imaging correlates of axonal swelling in chronic multiple sclerosis brains | Q48207806 | ||
| Neocortical neuronal, synaptic, and glial loss in multiple sclerosis | Q48413281 | ||
| Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. | Q48732598 | ||
| Axonal damage in acute multiple sclerosis lesions | Q48776354 | ||
| Demyelination increases radial diffusivity in corpus callosum of mouse brain | Q48908359 | ||
| Increased calpain I-mediated proteolysis, and preferential loss of dephosphorylated NF200, following traumatic spinal cord injury | Q57839879 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 180-189 | |
| P577 | publication date | 2009-12-27 | |
| P1433 | published in | Nature Neuroscience | Q1535359 |
| P1476 | title | HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage | |
| P478 | volume | 13 |
| Q28577939 | A Nuclear Attack on Traumatic Brain Injury: Sequestration of Cell Death in the Nucleus |
| Q39248784 | A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin (depsipeptide, Istodax(®)). |
| Q37384508 | A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation |
| Q47603807 | ABIN1 inhibits HDAC1 ubiquitination and protects it from both proteasome- and lysozyme-dependent degradation. |
| Q36818194 | Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer's disease |
| Q27307057 | Age-related memory impairment is associated with disrupted multivariate epigenetic coordination in the hippocampus |
| Q36635673 | Antiretroviral neurotoxicity |
| Q30391351 | Astaxanthin ameliorates prenatal LPS-exposed behavioral deficits and oxidative stress in adult offspring. |
| Q57562094 | Axonal Loss and Neurofilament Phosphorylation Changes Accompany Lesion Development and Clinical Progression in Multiple Sclerosis |
| Q35126104 | Axonal damage in multiple sclerosis. |
| Q34570124 | Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability? |
| Q43026728 | Beneficial effects of minocycline on cuprizone induced cortical demyelination |
| Q37787304 | Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies. |
| Q41063803 | Bioenergetic Failure in Rat Oligodendrocyte Progenitor Cells Treated with Cerebrospinal Fluid Derived from Multiple Sclerosis Patients |
| Q42464099 | Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo. |
| Q35836163 | C. elegans model of neuronal aging |
| Q64056936 | Catalytic-independent neuroprotection by SIRT1 is mediated through interaction with HDAC1 |
| Q34422726 | Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics |
| Q46468122 | Chronic demyelination-induced seizures |
| Q49884282 | Complex neuroprotective and neurotoxic effects of histone deacetylases. |
| Q24618949 | Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy |
| Q28576128 | Dexamethasone induces a putative repressor complex and chromatin modifications in the CRH promoter |
| Q35829521 | Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination |
| Q47265472 | Disturbed Glucose Metabolism in Rat Neurons Exposed to Cerebrospinal Fluid Obtained from Multiple Sclerosis Subjects |
| Q92755669 | Epigenetic Alterations Induced by Photothrombotic Stroke in the Rat Cerebral Cortex: Deacetylation of Histone h3, Upregulation of Histone Deacetylases and Histone Acetyltransferases |
| Q36948933 | Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment |
| Q34323841 | Epigenetic memory: the Lamarckian brain |
| Q35791723 | Epigenetic regulation of axon and dendrite growth |
| Q37381853 | Epigenetic regulation of sensory axon regeneration after spinal cord injury |
| Q33693885 | Epigenetics and the environment: in search of the "toleroasome" vital to execution of ischemic preconditioning |
| Q26995255 | Epigenetics of neural repair following spinal cord injury |
| Q36870458 | Evidence for a non-canonical role of HDAC5 in regulation of the cardiac Ncx1 and Bnp genes |
| Q93016306 | Excessive tubulin polyglutamylation causes neurodegeneration and perturbs neuronal transport |
| Q46255661 | Experimental autoimmune encephalomyelitis from a tissue energy perspective. |
| Q47926939 | Expression of Class I Histone Deacetylases in Ipsilateral and Contralateral Hemispheres after the Focal Photothrombotic Infarction in the Mouse Brain |
| Q37285451 | Flow-induced HDAC1 phosphorylation and nuclear export in angiogenic sprouting. |
| Q37685428 | HDAC inhibitors and neurodegeneration: at the edge between protection and damage |
| Q39829692 | HDAC1 in axonal degeneration: A matter of subcellular localization |
| Q94686423 | HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo |
| Q35581098 | HDAC1 regulates the proliferation of radial glial cells in the developing Xenopus tectum |
| Q36103678 | HDAC5 is a novel injury-regulated tubulin deacetylase controlling axon regeneration |
| Q28080593 | Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration |
| Q92927460 | Histone Deacetylase Inhibitors as Multitarget Ligands: New Players in Alzheimer's Disease Drug Discovery? |
| Q34179757 | Histone deacetylase inhibitors influence chemotherapy transport by modulating expression and trafficking of a common polymorphic variant of the ABCG2 efflux transporter |
| Q36347335 | Histone deacetylase inhibitors preserve function in aging axons |
| Q36318929 | Histone deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death |
| Q28575131 | Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children |
| Q35849307 | Histone/protein deacetylases and T-cell immune responses |
| Q37921168 | How histone deacetylases control myelination |
| Q35053115 | Identification of an intrinsic determinant critical for maspin subcellular localization and function. |
| Q33918201 | Image-guided synthesis reveals potent blood-brain barrier permeable histone deacetylase inhibitors. |
| Q93049244 | Implications of Diet and The Gut Microbiome in Neuroinflammatory and Neurodegenerative Diseases |
| Q55428388 | Inhibition of Histone Deacetylases Attenuates Morphine Tolerance and Restores MOR Expression in the DRG of BCP Rats. |
| Q34536980 | Insights into neuroepigenetics through human histone deacetylase PET imaging. |
| Q38543597 | Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis? |
| Q38215303 | Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors |
| Q38749124 | Ionomycin-induced calcium influx induces neurite degeneration in mouse neuroblastoma cells: analysis of a time-lapse live cell imaging system |
| Q37368725 | Lithium down-regulates histone deacetylase 1 (HDAC1) and induces degradation of mutant huntingtin. |
| Q59129045 | Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model |
| Q38196701 | Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. |
| Q35572468 | Mitochondria: key players in the neurotoxic effects of amphetamines. |
| Q28566372 | Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration |
| Q34077393 | Mitogen-activated protein kinase phosphatase 3 (MKP-3)-deficient mice are resistant to diet-induced obesity |
| Q48354362 | Molecular Genetic and Epigenetic Basis of Multiple Sclerosis |
| Q91910728 | Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis |
| Q41942567 | Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors |
| Q47122034 | Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer's disease |
| Q38812938 | Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology |
| Q30538837 | NBM-T-L-BMX-OS01, Semisynthesized from Osthole, Is a Novel Inhibitor of Histone Deacetylase and Enhances Learning and Memory in Rats |
| Q50495025 | NEX-TRAP, a novel method for in vivo analysis of nuclear export of proteins. |
| Q50026944 | Neurodegeneration in Progressive Multiple Sclerosis. |
| Q82616710 | Neurodegeneration: export disrupts transport |
| Q26824369 | Novel protective effects of histone deacetylase inhibition on stroke and white matter ischemic injury |
| Q35910495 | Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination |
| Q38534982 | Oligodendrocytes: Myelination and Axonal Support |
| Q28486241 | Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation |
| Q59800027 | PKCε phosphorylation regulates the mitochondrial translocation of ATF2 in ischemia-induced neurodegeneration |
| Q92489483 | Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease |
| Q92608702 | Polymeric sheet actuators with programmable bioinstructivity |
| Q48460212 | Progranulin protects against exaggerated axonal injury and astrogliosis following traumatic brain injury |
| Q92221378 | Promoter conservation in HDACs points to functional implications |
| Q41872258 | Promoting return of function in multiple sclerosis: An integrated approach |
| Q90689022 | RNA-binding protein altered expression and mislocalization in MS |
| Q34544950 | Reduced RAN expression and disrupted transport between cytoplasm and nucleus; a key event in Alzheimer's disease pathophysiology |
| Q82659772 | Renegade nuclear enzymes disrupt axonal integrity |
| Q38305861 | Reshaping the chromatin landscape after spinal cord injury |
| Q36539447 | Signaling Over Distances |
| Q37734207 | Signals to promote myelin formation and repair |
| Q82602601 | Slowly Progressive Axonal Degeneration in a Rat Model of Chronic, Nonimmune-Mediated Demyelination |
| Q64082973 | Structural prerequisites for CRM1-dependent nuclear export signaling peptides: accessibility, adapting conformation, and the stability at the binding site |
| Q38701633 | Subcellular Distribution of HDAC1 in Neurotoxic Conditions Is Dependent on Serine Phosphorylation. |
| Q36453005 | Subcellular Localization of Class I Histone Deacetylases in the Developing Xenopus tectum |
| Q41877371 | Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an in vitro feline model |
| Q41578052 | The Deacetylase HDAC6 Mediates Endogenous Neuritic Tau Pathology |
| Q39351825 | The Eutherian Armcx genes regulate mitochondrial trafficking in neurons and interact with Miro and Trak2. |
| Q38239792 | The central role of mitochondria in axonal degeneration in multiple sclerosis |
| Q91983661 | The histone deacetylase complex MiDAC regulates a neurodevelopmental gene expression program to control neurite outgrowth |
| Q37820143 | The tale of protein lysine acetylation in the cytoplasm. |
| Q92241239 | Therapeutic Effect of the Mitochondria-Targeted Antioxidant SkQ1 on the Culture Model of Multiple Sclerosis |
| Q36906420 | Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss |
| Q38156341 | Transcription and beyond: the role of mammalian class I lysine deacetylases |
| Q52667681 | Trichostatin A and Sirtinol Regulate the Expression and Nucleocytoplasmic Shuttling of Histone Deacetylases in All-Trans Retinoic Acid-Induced Differentiation of Neuroblastoma Cells. |
| Q35733643 | Understanding neurological disease mechanisms in the era of epigenetics |
| Q38087145 | Unique functional roles for class I and class II histone deacetylases in central nervous system development and function |
| Q48107874 | Visual experience dependent regulation of neuronal structure and function by histone deacetylase 1 in developing Xenopus tectum in vivo. |
| Q35126078 | Yy1 as a molecular link between neuregulin and transcriptional modulation of peripheral myelination |
Search more.